In a previous report (1) the disappearance curves of 181-11Abeled L-thyroxine and L-triiodothyronine were described in euthyroid subjects. The radioactive compounds were injected intravenously, and the radioactivity of the plasma or se- terminations. were carried out2 (4, 5). The BEI was done to avoid interference from inorganic iodine previously administered in the three instances where this had occurred. The two determinations were used interchangeably in the calculations of "organic iodine" figures ; PBI ordinarily exceeds BEI by approximately 0.6,ug. per cent in the absence of inorganic iodine (5). Calculations T-he injection of radiothyroxine was followed by a relatively rapid initial fall in radioactivity of the plasma (Figure 1 ). This was attributed to diffusion of the tracer out of the vascular compartment as it was distributed throughout the body's extrathyroidal organic iodine (EOI) pool. After two days the plasma radioactivity declined more gradually, resulting in a straight line when plotted seniilogarithmically. This slow exponential com-
Syracwse, N. Y.) (Submitted for publication February 8, 1956 ; accepted March 15, 1956) In a previous report (1) the disappearance curves of 181-11Abeled L-thyroxine and L-triiodothyronine were described in euthyroid subjects. The radioactive compounds were injected intravenously, and the radioactivity of the plasma or serumnwas determined at intervals for approximately two weeks. Estimations were made of the rate of degradation of organic (thyroxine) iodine. In the present woxk, this approach has been extended to myxedernatous and thyrotoxic patients with findings agreeing in general with Ingbar and Freinkel (2) whose methods were similar, as well as Berson and Yalow (3) who employed entirely different methods. In the effort to elucidate the role of peripieral tissue metabolism in hormone degradation rate, studies were carried out during treatment of myxedema, and in subjects exhibiting hypermetabolism without evidence of endocrine disease.
MATERIAL AND METHODS
Tracer amounts of PI'-labeled L-thyroxine' were injected intravenously,' and heparinized 'venous blood samples were taken 10'minutes after injection and daily or on alternate days for two weeks or longer. Prior to injection the radiothyroxine was kept in siliconed glassware and syringes to prevent adsorption by vessel walls. The plasma radioactivity was assayed in a well-type scintillation counter which recorded approximately one million counts per minute per microcurie of I' (42 per cent overall efficiency) above a background of 130 cpm. Corrections for radioactive decay were made when necessary. Usually all plasma samples from a given patient and diluted aliquots of the administered compound were counted together after conclusion of the study, obviating the need for decay correction.
In all subjects one or more plasma protein bound iodine (PBI) or butanol extractable iodine (BEI) de- 'Approximately SO Uc. in 2 to 10(,ug. thyroxine, supplied by Abbott Laboratories, Oak Ridge, Tennessee.
terminations. were carried out2 (4, 5) . The BEI was done to avoid interference from inorganic iodine previously administered in the three instances where this had occurred. The two determinations were used interchangeably in the calculations of "organic iodine" figures; PBI ordinarily exceeds BEI by approximately 0.6,ug. per cent in the absence of inorganic iodine (5). Calculations T-he injection of radiothyroxine was followed by a relatively rapid initial fall in radioactivity of the plasma ( Figure 1 Semilogarithmic-plot. The flattening of the curve after the eighth day was attributed to reutilization of the I' label from degraded radiothyroxine and its reappearance in the circulation as newly synthesized radiothyroxine. With iodine prefeeding, the curves remained linear throughout in thyrotoxic patients. metabolic degradation of the administered radiothyroxine, hence a measure of the turnover rate of the hormone.
The half-time of thyroxine turnover was obtained graphically from the linear component of the disappearance curve extrapolated back to zero time ( Figure 1 ). The turnover rate was computed from the half-time. 3 As an example, the calculations for subject R. R. follow:
Half-time (t1) = 6.7 days (obtained graphically. Figure 1 The product of the EOI pool and the turnover rate (k) gave the degradation rate in micrograms of organic iodine per day. 552 ,g. (EOI pool) X 10.4%o per day (k) = 58 g. I per day. This figure represented the rates of formation and degradation, which are identical in a steady state with constant EOI pool. The calculations depend upon the assumption that a steady state existed, which appears reasonable in the absence of significant alterations in the clinical condition.
Clinical material
The subjects selected for study consisted of the following groups:
Normal. Eight healthy medical student volunteers. Thyrotoxicosis. Six clinically typical cases, verified by abnormally high plasma PBI concentrations. C. S. was untreated. The other subjects except M. 0. were receiving 15 drops of Lugol's solution daily, begun one or more weeks prior to study. M. 0. was maintained nearly In previous studies (1, 6) employing the I' label for turnover rates, Lugol's solution or potassium iodide had been administered to minimize thyroid uptake and promote urinary excretion of I' liberated on degradation of the labeled compound. This precaution of iodine prefeeding to prevent reutilization of the label and its reappearance in the circulation as newly formed radiothyroxine was not carried out by Ingbar and Freinkel (2) whose data show no evidence of significant interference from reutilization, except in hyperthyroid subjects. Sufficient reutilization to affect radiothyroxine disappearance curves significantly would not be expected in myxedema because of negligible thyroid activity, or even in normals, because of mathematical considerations of the turnover and magnitude of the thyroidal iodine pool (3). This inference receives support from the data of R. R., the hospital control subject with multiple sclerosis; the addition of potassium iodide midway through the study produced no visible change in the disappearance curve (Figure 1) . Other similar findings, not included in the present report, bear out this conclusion. Moreover, the other euthyroid control subjects in the present work received no added iodine, and had disappearance curves which did not differ significantly from those in the euthyroid series previously reported (1), where iodine was administered.
On the other hand, the curve obtained in the hyperthyroid subject C. S. studied without iodine prefeeding shows a break after the eighth day (Figure 2) . The subsequent flattening of the curve was attributed to secretion of newly synthesized labeled hormone which evidently may be quite appreciable in untreated thyrotoxicosis. Consequently, the other thyrotoxic subjects, except M. O., were given 15 drops of Lugol's solution daily prior to and during the studies, and must be considered in partial though slight remission. Subject M. 0. was maintained nearly euthyroid for three weeks prior to and throughout the study with Tapazole@&, later propylthiouracil. The euthyroid and myxedematous subjects were not given added iodine.
RESULTS
The disappearance curves (Figure 3) showed a slower than normal rate of fall in myxedema, and an accelerated turnover rate in thyrotoxicosis. The extrathyroidal organic iodine (EOI) pools were diminished in myxedema and increased in thyrotoxicosis (Tables I and II) .
The absolute degradation rates, being the products of the pools and turnovers, showed even wider divergences between the different groups.
Within the hyperthyroid group, the highest values occurred in C. S., the untreated patient, while the lowest were seen in M. O., the patient who was maintained nearly euthyroid with antithyroid medication.
The cases of hypermetabolism without endocrine disease exhibited degradation rates lower than the thyrotoxic patients but still significantly greater than normal. The highest values in a normal subject, P. R., approximated the lowest rate in a hypermetabolic leukemic patient, P. N. In the latter case, hydrocortisone and triethylene melamine (T.E.M.) therapy were instituted shortly after the start of the study, and the temperature declined from 104°F. to 1000 F.; whether or not the BMR declined correspondingly was not determined because of gingival bleeding.
The short term effect of massive thyroid replacement therapy was investigated to determine whether it would alter the slowly falling disappearance curve in myxedema. Large intravenous doses of 1-thyroxine resulting in marked elevation of plasma PBI failed to produce evident change in curves in studies continued 7 to 10 days after therapy ( Figure 4 and Table III ). The amounts of thyroxine administered were sufficient to increase markedly the EOI pool. Because of its prompt calorigenic effect (7, 8) specification of the precise pathways of removal. The calculations, in all except three subjects, were based upon plasma PBI determinations, which give slightly higher values than BEI, evidently a more accurate measurement of circulating thyroid hormone (5). The general relationship between level of thyroid function and rate of peripheral degradation of hormone is apparent from the present study as well as the work of Berson and Yalow (3) and of Ingbar and Freinkel (2). Figure 5 illustrates that degradation rate was related to the plasma PBI concentration, the points showing a considerable scatter in the higher ranges. This scatter was not greatly improved by employing a log-log plot of degradation rate as a function of the square of PBI concentration (3).
It does not necessarily follow, however, that the rate of degradation is controlled directly by the PBI concentration as a mass action effect. On the contrary, the failure of large doses of thyroxine, triiodothyronine, or both to alter the disappearance curve in myxedema suggests that, under given circumstances, a fixed proportion of the extrathyroidal organic iodine pool is removed per day, even when the pool is acutely increased by intravenous thyroxine. This fixed rate persisted, even with elevation of the BMR to normal in short term triiodothyronine experiments. Whether the kinetics would be altered by several weeks' or months' maintenance in the euthyroid state remains to be determined. It is conceivable that the mechanism for degrading thyroxine might, like the changes in the integument, require many months of replacement therapy before appreciable reversion to normal. 5 The unaltered disappearance curves (and hence unaltered daily fractional removal rates) observed after large intravenous doses of thyroxine indicated a markedly elevated absolute amount of hormone degraded, since the administered thyroxine greatly exceeded the amount originally pres- In considering radiothyroxine turnover studies, attention should be given to the possibility that thyroxine may exert its metabolic effect only after conversion to triiodothyronine in the peripheral tissues. Gross and Leblond (11) demonstrated that "unknown 1" (later shown to be triiodothyronine) was formed from thyroxine in peripheral tissues of thyroidectomized animals. Pitt-Rivers, Stanbury, and Rapp (12) found labeled triiodothyronine in the plasma of athyreotic patients after administration of I'l5-labeled thyroxine. Albright, Larson, and Tust (13) (14) have shown that kidney slices from thyroidectomized rats convert thyroxine to triiodothyronine more slowly than slices from normal rats, while the kidneys from thyrotoxic animals (fed desiccated thyroid or exposed to cold) accomplished this conversion at an accelerated rate. The postulated adaptive enzyme system for thyroxine deiodination may well have relevance for the disappearance curves of the present study. An additional factor which cannot be excluded at this time is possible differences in thyroxine binding protein, a problem which requires further study.
Elevated degradation rates occurred in the hypermetabolic subjects with normal plasma PBI concentration. This finding of dissociation between PBI and degradation rate would argue further against the assumption that the rate of removal of hormone is a mass action phenomenon determined directly by PBI concentration. MoreoVer, Castor and Beierwaltes (15) have reported depression of PBI concentration in human subjects made hypermetabolic by administration of dinitrophenol for two days, an observation which could be interpreted as acutely accelerated thyroxine degradation. In the absence of more extensive information with regard to mechanisms of hormone removal, the data would suggest that peripheral tissue metabolism, or some function thereof, has major importance in determining hormone degradation rate. SUMMARY 1. The rate of peripheral degradation of circulating thyroid hormone was studied with IIll-labeled L-thyroxine in normal subjects, patients with thyroid disease, and hypermetabolic patients without endocrine disease (leukemia, fever).
2. After intravenous injection of a tracer amount of radiothyroxine the rate of disappearance of plasma radioactivity was determined.
3. The slow exponential component of the disappearance curve was interpreted as the rate of metabolic degradation.
4. The extrathyroidal organic iodine (EOI) pools calculated by the isotope dilution principle were diminished in myxedema and increased in thyrotoxicosis, as compared with the normals.
5. The turnover rates of extrathyroidal hormone obtained from the half-times of disappearance were slower than normal in myxedema, and accelerated in thyrotoxicosis.
6. The absolute organic iodine degradation rates, being the products of the pools and turnovers, showed even wider divergences between the different groups. The mean values + standard deviation in micrograms of iodine per day (adjusted to 1.73 m2 surface area) were as follows: 7. The hypermetabolic subjects without endocrine disease had increases in pools, turnovers, and degradation rates, although less pronounced than in thyrotoxicosis. The elevated values in nonspecific hypermetabolism suggested that peripheral tissue metabolism, or some function thereof, has a major role in determining hormone degradation rate.
8. Administration of large amounts of thyroxine or triiodothyronine or both to myxedematous subjects failed to alter the shape of the disappearance curve. This indicated turnover of a fixed proportion of the EOI pool daily, during short term studies, despite marked elevation of the plasma PBI concentration, enlargement of the EOI pool, and increase in the absolute organic iodine degradation rate.
